Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01-AR065977, K23-AR062127)
National Center for Complementary and Integrative Health (K23-AT009374)
Arthritis Research UK
Text and Data Mining valid from 2020-01-31
Received: 18 September 2019
Accepted: 16 January 2020
First Online: 31 January 2020
Ethics approval and consent to participate
: The Outer North East London Research Ethics Committee approved the study. The Chingford Study has met all criteria for ethical standards regarding human studies as described in the 1964 Declaration of Helsinki and all amendments. Each study participant provided written informed consent before participating.
: Not applicable.
: Jeffrey B. Driban is a member of the Editorial Board of BMC Musculoskeletal Disorders. Charles B. Eaton and Jeffrey B. Driban reported grants with money paid to their institutions from the National Institutes of Health. Jeffrey B. Driban also reported payment for lectures from Pfizer, Inc. and consultancy from Pfizer/Lily. Nigel Arden reported payment for consultancy from Merck, Pfizer/Lily, Flexion, and Regeneron and payment to his institution from Merck.